Sign in or Register   Sign in or Register
  |  

Rat Anti-IL13 Recombinant Antibody (JES10-5A2) (CBMAB-I0396-YY)

This product is Rat antibody that recognizes IL13. The antibody JES10-5A2 can be used for immunoassay techniques such as: ELISA, ELISpot, ICFC, IHC, Neut, WB
See all IL13 antibodies
Published Data

Summary

Host Animal
Rat
Specificity
Human
Clone
JES10-5A2
Antibody Isotype
IgG1, κ
Application
ELISA, ELISpot, ICFC, IHC, Neut, WB

Basic Information

Specificity
Human
Antibody Isotype
IgG1, κ
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format
Liquid
Buffer
PBS, pH 7.2
Concentration
1.0 mg/ml
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

Full Name
Interleukin 13
Introduction
This gene encodes an immunoregulatory cytokine produced primarily by activated Th2 cells. This cytokine is involved in several stages of B-cell maturation and differentiation. It up-regulates CD23 and MHC class II expression, and promotes IgE isotype switching of B cells. This cytokine down-regulates macrophage activity, thereby inhibits the production of pro-inflammatory cytokines and chemokines. This cytokine is found to be critical to the pathogenesis of allergen-induced asthma but operates through mechanisms independent of IgE and eosinophils. This gene, IL3, IL5, IL4, and CSF2 form a cytokine gene cluster on chromosome 5q, with this gene particularly close to IL4.
Entrez Gene ID
UniProt ID
Alternative Names
Interleukin 13
Function
Cytokine (PubMed:8096327, PubMed:8097324).

Inhibits inflammatory cytokine production (PubMed:8096327).

Synergizes with IL2 in regulating interferon-gamma synthesis (PubMed:8096327).

May be critical in regulating inflammatory and immune responses (PubMed:8096327, PubMed:8097324).

Positively regulates IL31RA expression in macrophages (By similarity).
Biological Process
Cellular response to cytokine stimulus Source: Ensembl
Cellular response to mechanical stimulus Source: Ensembl
Immune response Source: InterPro
Inflammatory response Source: ProtInc
Macrophage activation Source: ARUK-UCL
Microglial cell activation Source: Ensembl
Negative regulation of complement-dependent cytotoxicity Source: AgBase
Negative regulation of endothelial cell apoptotic process Source: AgBase
Negative regulation of inflammatory response Source: ARUK-UCL
Negative regulation of lung ciliated cell differentiation Source: BHF-UCL
Negative regulation of NAD(P)H oxidase activity Source: Ensembl
Negative regulation of neuron death Source: Ensembl
Negative regulation of transforming growth factor beta production Source: Ensembl
Positive regulation of B cell proliferation Source: Ensembl
Positive regulation of cold-induced thermogenesis Source: YuBioLab
Positive regulation of connective tissue growth factor production Source: Ensembl
Positive regulation of gene expression Source: ARUK-UCL
Positive regulation of immunoglobulin production Source: Ensembl
Positive regulation of interleukin-10 production Source: ARUK-UCL
Positive regulation of lung goblet cell differentiation Source: BHF-UCL
Positive regulation of macrophage activation Source: Ensembl
Positive regulation of mast cell degranulation Source: Ensembl
Positive regulation of pancreatic stellate cell proliferation Source: Ensembl
Positive regulation of protein secretion Source: Ensembl
Positive regulation of release of sequestered calcium ion into cytosol Source: Ensembl
Positive regulation of smooth muscle cell proliferation Source: Ensembl
Positive regulation of tyrosine phosphorylation of STAT protein Source: Ensembl
Regulation of proton transport Source: Ensembl
Response to ethanol Source: Ensembl
Response to lipopolysaccharide Source: Ensembl
Response to nicotine Source: Ensembl
Cellular Location
Secreted
Involvement in disease
Allergic rhinitis (ALRH):
A common disease with complex inheritance characterized by mucosal inflammation caused by allergen exposure.

Jia, F., Zhao, Q., Shi, P., Liu, H., & Zhang, F. (2022). Dupilumab: Advances in the off‐label usage of IL4/IL13 antagonist in dermatoses. Dermatologic Therapy, 35(12), e15924.

Stern, L. A., Gholamin, S., Moraga, I., Yang, X., Saravanakumar, S., Cohen, J. R., ... & Brown, C. E. (2022). Engineered IL13 variants direct specificity of IL13Rα2-targeted CAR T cell therapy. Proceedings of the National Academy of Sciences, 119(33), e2112006119.

Noto, C. N., Hoft, S. G., Bockerstett, K. A., Jackson, N. M., Ford, E. L., Vest, L. S., & DiPaolo, R. J. (2022). IL13 Acts directly on gastric epithelial cells to promote Metaplasia Development during Chronic Gastritis. Cellular and Molecular Gastroenterology and Hepatology, 13(2), 623-642.

Campanati, A., Orciani, M., Marani, A., Di Vincenzo, M., Magi, S., Gregoriou, S., ... & Offidani, A. (2022). Mesenchymal stem cells profile in adult atopic dermatitis and effect of IL4-IL13 inflammatory pathway inhibition In vivo: Prospective case-control study. journal of clinical medicine, 11(16), 4759.

Ramonell, R. P., & Iftikhar, I. H. (2020). Effect of anti-IL5, anti-IL5R, anti-IL13 therapy on asthma exacerbations: a network meta-analysis. Lung, 198, 95-103.

Hirano, I., Collins, M. H., Assouline-Dayan, Y., Evans, L., Gupta, S., Schoepfer, A. M., ... & HEROES Study Group. (2019). RPC4046, a monoclonal antibody against IL13, reduces histologic and endoscopic activity in patients with eosinophilic esophagitis. Gastroenterology, 156(3), 592-603.

Heiss, J. D., Jamshidi, A., Shah, S., Martin, S., Wolters, P. L., Argersinger, D. P., ... & Lonser, R. R. (2018). Phase I trial of convection-enhanced delivery of IL13-Pseudomonas toxin in children with diffuse intrinsic pontine glioma. Journal of Neurosurgery: Pediatrics, 23(3), 333-342.

Rahal, O. M., Wolfe, A. R., Mandal, P. K., Larson, R., Tin, S., Jimenez, C., ... & Woodward, W. A. (2018). Blocking interleukin (IL) 4-and IL13-mediated phosphorylation of STAT6 (Tyr641) decreases M2 polarization of macrophages and protects against macrophage-mediated radioresistance of inflammatory breast cancer. International Journal of Radiation Oncology* Biology* Physics, 100(4), 1034-1043.

Hamzei Taj, S., Le Blon, D., Hoornaert, C., Daans, J., Quarta, A., Praet, J., ... & Hoehn, M. (2018). Targeted intracerebral delivery of the anti-inflammatory cytokine IL13 promotes alternative activation of both microglia and macrophages after stroke. Journal of neuroinflammation, 15, 1-17.

Venkataramani, S., Low, S., Weigle, B., Dutcher, D., Jerath, K., Menzenski, M., ... & Erb, K. J. (2018). Design and characterization of Zweimab and Doppelmab, high affinity dual antagonistic anti-TSLP/IL13 bispecific antibodies. Biochemical and biophysical research communications, 504(1), 19-24.

Ask a question We look forward to hearing from you.
0 reviews or Q&As
Loading...
Have you used Rat Anti-IL13 Recombinant Antibody (JES10-5A2)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Documents

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Go to
Compare